Ryuji Matsumoto

11PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 14, 2026
Stage- and Age-Specific Survival According to Histological Subtype in Renal Cell Carcinoma: A Nationwide Hospital-Based Cancer Registry Analysis in Japan.

|Jan 08, 2026
Solitary Fibrous Tumor With Doege-Potter Syndrome Successfully Treated With Preoperative Transcatheter Arterial Embolization and Complete Excision; A Case Report.

Rei Narimatsu, Ryuji Matsumoto, Haruka Miyata

|Jul 29, 2025
[177Lu]Lu-PSMA-617 in Patients with Progressive PSMA+ mCRPC Treated With or Without Prior Taxane-Based Chemotherapy: A Phase 2, Open-Label, Single-Arm Trial in Japan.

Kouji Izumi, Ryuji Matsumoto, Yusuke Ito

|Apr 08, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN Study.

Leandro Blas, Masaki Shiota, Takuma Kato

|Dec 07, 2023
TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma.

Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara

|Nov 07, 2022
Metastatic neuroendocrine carcinoma of right adrenal gland successfully treated with laparoscopic adrenalectomy after multimodal therapy.

Yusuke Yamagata, Takashige Abe, Naoya Iwahara

Pageof 2

Frequent Collaborators

2 joint publications

Naoya Iwahara

2 joint publications

Akira Yokomizo

2 joint publications

Nobuaki Matsubara

1 joint publications

Kanta Hori